Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA4 | P22748 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pivalate SCHEMBL31329484 | 0.96 | — | — | |
| Pivalate SCHEMBL2349136 | 0.92 | — | — | |
| Pivalate SCHEMBL18451999 | 0.92 | — | — | |
| Pivalate SCHEMBL1685640 | 0.92 | CA1 (0.43) | CA1CA4ALDH1A1TSHRFAHD1 | |
| Pivalate SCHEMBL1043179 | 0.92 | — | — | |
| Pivalate SCHEMBL25243131 | 0.92 | CA1 (0.43) | CA1CA4ALDH1A1TSHRFAHD1 | |
| Pivalate SCHEMBL1314523 | 0.92 | CA1 (0.43) | CA1CA4ALDH1A1TSHRFAHD1 | |
| Pivalate SCHEMBL4652796 | 0.92 | CA1 (0.43) | CA1CA4ALDH1A1TSHRFAHD1 | |
| Pivalate SCHEMBL2204587 | 0.92 | CA1 (0.43) | CA1CA4ALDH1A1TSHRFAHD1 | |
| Pivalate SCHEMBL101921 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5585202-A | METAL OXYHALIDES PHOTOSTIMULATED LUMINESCENCE COMPRISING STABILIZER PREVENTING IODINE YELLOWING | EASTMAN KODAK COMPANY (US) | 1996-12-17 | — | — | US | claimed |
| WO-2025040517-A1 | METHOD FOR PRODUCING A LAYER COMPOSED OF PEROVSKITE, LAYER COMPOSED OF PEROVSKITE AND USE OF THE LAYER COMPOSED OF PEROVSKITE | Friedrich-Alexander-Universität Erlangen-Nürnberg, Körperschaft des öffentlichen Rechts (DE) | 2025-02-27 | — | — | WO | disclosed |
| US-8673552-B2 | Druggable regions in the dengue virus envelope glycoprotein and methods of using the same | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2014-03-18 | — | — | US | disclosed |
| US-20100298164-A1 | STRUCTURE-BASED APPROACH TO DESIGN OF INHIBITORS OF PROTEIN-PROCESSIVITY FACTOR INTERACTIONS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2010-11-25 | — | — | US | disclosed |
| US-7799547-B2 | Purified polypeptides from Staphylococcus aureus | AFFINIUM PHARMACEUTICALS, INC. (CA) | 2010-09-21 | — | — | US | disclosed |
| US-20100105151-A1 | Novel Druggable Regions in the Dengue Virus Envelope Glycoprotein and Methods of Using the Same | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2010-04-29 | — | — | US | disclosed |
| US-7601526-B2 | Purified FabI polypeptides from Fransicella tularensis | AFFINIUM PHARMACEUTICALS, INC. (CA) | 2009-10-13 | — | — | US | disclosed |
| US-20090132178-A1 | Crystalline enoyl-(acyl-carrier-protein) Reductase from Heliobacter Pylori | AFFINIUM PHARMACEUTICALS, INC. (CA) | 2009-05-21 | — | — | US | disclosed |
| US-7524624-B2 | Druggable regions in the dengue virus envelope glycoprotein and methods of using the same | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2009-04-28 | — | — | US | disclosed |
| US-20090035753-A9 | Novel druggable regions in the dengue virus envelope glycoprotein and methods of using the same | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-02-05 | — | — | US | disclosed |
| EP-0862621-A1 | CRYSTALLINE FRAP COMPLEX | CORNELL RESEARCH FOUNDATION, INC. (US) | 1998-09-09 | — | — | EP | disclosed |
| EP-0847443-A1 | CRYSTALLINE ZAP FAMILY PROTEINS | ARIAD PHARMACEUTICALS, INC. (US) | 1998-06-17 | — | — | EP | disclosed |
| WO-1997015659-A1 | CRYSTALLINE FRAP COMPLEX | CORNELL RESEARCH FOUNDATION, INC. (US) | 1997-05-01 | — | — | WO | disclosed |
| WO-1997008300-A1 | CRYSTALLINE ZAP FAMILY PROTEINS | ARIAD PHARMACEUTICALS, INC. (US) | 1997-03-06 | — | — | WO | disclosed |
| US-5585202-A | METAL OXYHALIDES PHOTOSTIMULATED LUMINESCENCE COMPRISING STABILIZER PREVENTING IODINE YELLOWING | EASTMAN KODAK COMPANY (US) | 1996-12-17 | — | — | US | disclosed |
| EP-0646599-A2 | Modification of pertussis toxin | CONNAUGHT LABORATORIES LIMITED (CA) | 1995-04-05 | — | — | EP | disclosed |
| US-4554397-A | Use of a catalyst comprising nickel and at least one metal from the group consisting of tin, germanium and lead | INSTITUT FRANCAIS DU PETROLE (FR) | 1985-11-19 | — | — | US | disclosed |
| US-4247689-A | Preparation of isocyanate derivatives of 1,3[oxazoles, oxazines, diazoles and diazines] | BAYER AKTIENGESELLSCHAFT (DE) | 1981-01-27 | — | — | US | disclosed |
| US-4242489-A | Process for preparing polyurethanes | BAYER AKTIENGESELLSCHAFT (DE) | 1980-12-30 | — | — | US | disclosed |
| US-4173567-A | Isocyanate derivatives of 1,3[oxazoles, oxazines, diazoles and diazines] | BAYER AKTIENGESELLSCHAFT (DE) | 1979-11-06 | — | — | US | disclosed |